🇺🇸 FDA

Company profile · Sponsor

Abbott

Abbott Laboratories

E3E64B1 · EMA pharma Moscow, RU
Pipeline
1
Drugs
0
Patents
0

Quick answer

Abbott (E3E64B1) is a pharma company. headquartered in Moscow, RU. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E3E64B1
Exchange EMA
Company type pharma
Headquarters Moscow, RU

Pipeline (1)

Search pipeline →

  1. Efluelda Injektionssuspension in einer Fertigspritze Trivalenter Influenza-Spaltimpfstoff (inaktiviert), 60 Mikrogramm HA/Stamm, Influvac, suspensie voor injectie 0,5 ml (influenza vaccin, oppervlakte antigeen, geïnactiveerd)., Trivalent Influenza Vaccine - High Dose (TIV-HD)

    Abbott

    Influenza immunisation

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is Abbott?

Abbott (E3E64B1) is a pharma company. headquartered in Moscow, RU. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does Abbott sponsor?

We track 1 ClinicalTrials.gov-linked program for Abbott, including Efluelda Injektionssuspension in einer Fertigspritze Trivalenter Influenza-Spaltimpfstoff (inaktiviert), 60 Mikrogramm HA/Stamm, Influvac, suspensie voor injectie 0,5 ml (influenza vaccin, oppervlakte antigeen, geïnactiveerd)., Trivalent Influenza Vaccine - High Dose (TIV-HD). Open each program for phase, modality, NCT IDs, and indication details.

Where does Abbott company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.